Literature DB >> 24923897

Thymoma with loss of keratin expression (and giant cells): a potential diagnostic pitfall.

Patrick Adam1, Samy Hakroush, Ilse Hofmann, Sonja Reidenbach, Alexander Marx, Philipp Ströbel.   

Abstract

Due to its profound therapeutic consequences, the distinction between thymoma and T-lymphoblastic lymphoma in needle biopsies is one of the most challenging in mediastinal pathology. One essential diagnostic criterion favouring thymoma is the demonstration of increased numbers of keratin-positive epithelial cells by immunohistochemistry. Loss of keratin expression in neoplastic epithelial cells could lead to detrimental misdiagnoses. We here describe a series of 14 thymic epithelial tumours (11 type B2 and B3 thymomas, 3 thymic carcinomas) with loss of expression of one or more keratins. Cases were analysed for expression of various keratins and desmosomal proteins by immunohistochemistry and immunofluorescence and compared with 45 unselected type B thymomas and 24 thymic carcinomas arranged in a multitissue histological array. All 14 cases showed highly reduced expression of at least one keratin, three cases were completely negative for all keratins studied. Of the 14 cases, 13 showed strong nuclear expression of p63. Expression of desmosomal proteins was preserved, suggesting intact cell contact structures. Loss of expression of broad-spectrum-keratins and K19 was observed in 3 and 5 % of unselected thymomas and in 30 and 60 % of thymic carcinomas. A proportion of keratin-depleted thymomas contained giant cells, reminiscent of thymic nurse cells. Loss of keratin expression in type B2 and B3 thymomas is an important diagnostic pitfall in the differential diagnosis with T-lymphoblastic lymphoma and can be expected in 5 % of cases. A panel of epithelial markers including p63 is warranted to ensure correct diagnosis of keratin-negative mediastinal tumours.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24923897     DOI: 10.1007/s00428-014-1606-6

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  13 in total

1.  Flow cytometry in the differential diagnosis of lymphocyte-rich thymoma from precursor T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma.

Authors:  Shiyong Li; Jonathan Juco; Karen P Mann; Jeannine T Holden
Journal:  Am J Clin Pathol       Date:  2004-02       Impact factor: 2.493

2.  p63 Is essential for the proliferative potential of stem cells in stratified epithelia.

Authors:  Makoto Senoo; Filipa Pinto; Christopher P Crum; Frank McKeon
Journal:  Cell       Date:  2007-05-04       Impact factor: 41.582

3.  Cytokeratin expression in human thymus: immunohistochemical mapping.

Authors:  E Shezen; E Okon; H Ben-Hur; O Abramsky
Journal:  Cell Tissue Res       Date:  1995-01       Impact factor: 5.249

4.  Thymoma mimicking lymphoblastic lymphoma: a pitfall in fine-needle aspiration biopsy interpretation.

Authors:  H D Friedman; R E Hutchison; L J Kohman; C N Powers
Journal:  Diagn Cytopathol       Date:  1996-03       Impact factor: 1.582

Review 5.  Thymoma and thymic carcinoma.

Authors:  Federico Venuta; Erino A Rendina; Marco Anile; Tiziano de Giacomo; Domenico Vitolo; Giorgio F Coloni
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-01-13

Review 6.  Thymoma and thymic carcinoma: molecular pathology and targeted therapy.

Authors:  Philipp Ströbel; Peter Hohenberger; Alexander Marx
Journal:  J Thorac Oncol       Date:  2010-10       Impact factor: 15.609

7.  Common cellular and diverse genetic basis of thymoma-associated myasthenia gravis: role of MHC class II and AIRE genes and genetic polymorphisms.

Authors:  Philipp Ströbel; Wen-Yu Chuang; Sergei Chuvpilo; Andreas Zettl; Tiemo Katzenberger; Hubert Kalbacher; Peter Rieckmann; Wilfred Nix; Berthold Schalke; Ralf Gold; Hans-Konrad Müller-Hermelink; Pärt Peterson; Alexander Marx
Journal:  Ann N Y Acad Sci       Date:  2008       Impact factor: 5.691

8.  Characterization of human thymic epithelial cell surface antigens: phenotypic similarity of thymic epithelial cells to epidermal keratinocytes.

Authors:  D D Patel; L P Whichard; G Radcliff; S M Denning; B F Haynes
Journal:  J Clin Immunol       Date:  1995-03       Impact factor: 8.317

9.  Thymic nurse cells exhibit epithelial progenitor phenotype and create unique extra-cytoplasmic membrane space for thymocyte selection.

Authors:  Tonya M Hendrix; Rajendra V E Chilukuri; Marcia Martinez; Zachariah Olushoga; Andrew Blake; Moazzam Brohi; Christopher Walker; Michael Samms; Jerry C Guyden
Journal:  Cell Immunol       Date:  2009-12-24       Impact factor: 4.868

10.  New consensus nomenclature for mammalian keratins.

Authors:  Jürgen Schweizer; Paul E Bowden; Pierre A Coulombe; Lutz Langbein; E Birgitte Lane; Thomas M Magin; Lois Maltais; M Bishr Omary; David A D Parry; Michael A Rogers; Mathew W Wright
Journal:  J Cell Biol       Date:  2006-07-10       Impact factor: 10.539

View more
  4 in total

Review 1.  The 2015 World Health Organization Classification of Tumors of the Thymus: Continuity and Changes.

Authors:  Alexander Marx; John K C Chan; Jean-Michel Coindre; Frank Detterbeck; Nicolas Girard; Nancy L Harris; Elaine S Jaffe; Michael O Kurrer; Edith M Marom; Andre L Moreira; Kiyoshi Mukai; Attilio Orazi; Philipp Ströbel
Journal:  J Thorac Oncol       Date:  2015-10       Impact factor: 15.609

Review 2.  [Ectopic thymic tissue and ectopic thymic tumors].

Authors:  A Marx; T Rüdiger; E Rößner; A Tzankov; V T de Montpréville; R R Rieker; P Ströbel; C-A Weis
Journal:  Pathologe       Date:  2018-09       Impact factor: 1.011

Review 3.  [Thymomas].

Authors:  A Marx; C-A Weis; P Ströbel
Journal:  Pathologe       Date:  2016-09       Impact factor: 1.011

Review 4.  Molecular pathology of thymomas: implications for diagnosis and therapy.

Authors:  Alexander Marx; Djeda Belharazem; De-Hyung Lee; Zoran V Popovic; Christoph Reißfelder; Berthold Schalke; Sebastian Schölch; Philipp Ströbel; Cleo-Aron Weis; Yosuke Yamada
Journal:  Virchows Arch       Date:  2021-03-05       Impact factor: 4.064

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.